Get the Stockscreener App
41.64
0.75%
0.31
After Hours:
41.64
Apogee Therapeutics Inc Stock (APGE) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-09-30 |
| Period Length | 3 Months | 3 Months |
| Revenues |
-
|
- |
Operating Expenses
|
57.09%
38.18
|
24.30 |
| Operating Income/Loss |
57.09%
-38.18
|
-24.30 |
| Income/Loss From Continuing Operations Before Tax |
54.00%
-32.09
|
-20.84 |
| Income/Loss From Continuing Operations After Tax |
54.00%
-32.09
|
-20.84 |
|
Net Income/Loss
|
54.00%
-32.09
|
-20.84 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
21.73%
50.19
|
41.23 |
| Diluted Average Shares |
21.73%
50.19
|
41.23 |
| Basic Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Diluted Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):